Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

A survey of the European Society of Clinical Pharmacy members' research involvement, and associated enablers and barriers

D. Stewart, V. Paudyal, C. Cadogan, A. Hazen, B. Okuyan, M. Lutters, M. Henman, D. Fialová

. 2020 ; 42 (4) : 1073-1087. [pub] 20200519

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21020298
E-zdroje Online Plný text

NLK ProQuest Central od 2011-02-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2011-02-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest) od 2011-02-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2011-02-01 do Před 1 rokem

Odkazy

PubMed 32430883
DOI 10.1007/s11096-020-01054-9
Knihovny.cz E-zdroje

Background Building research capacity of European Society of Clinical Pharmacy (ESCP) members aligns to the organisation's aim of advancing research. Objective To determine members' aspirations and needs in research training and practice, and to explore ways in which ESCP could provide support. Setting ESCP's international membership. Method Cross-sectional survey of members in 2018, followed by focus groups with samples of respondents attending an ESCP symposium. Survey items were: research activities; interests, experience and confidence; and Likert statements on research conduct. Principal component analysis (PCA) clustering of Likert statements from a previous study was used, with scores for each component calculated. Focus groups discussed barriers to research and how ESCP could provide support. Data analysis involved collating and comparing all themes. Main outcome measures Research interest, experience and confidence; attitudinal items; barriers to research; ESCP support. Results The response rate was 16.7% (83/499), with 89.2% (n = 74) involved in research and 79.5% (n = 66) publishing research in the preceding 2 years. While overwhelmingly positive, responses were more positive for research interest than experience or confidence. PCA component scores (support/opportunities, motivation/outcomes, and roles/characteristics) were positive. Thirteen members participated in focus groups, identifying barriers of: insufficient collaboration; lack of knowledge, skills, training; unsupportive environment; insufficient time; and limited resources. ESCP could support through mentorship, collaboration, education and funding. Conclusion Study participants were highly active, interested, experienced, confident and positive regarding research. There is an opportunity for ESCP to harness these activities and provide support in the form of mentoring, education and training, and facilitating collaboration.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020298
003      
CZ-PrNML
005      
20210830101927.0
007      
ta
008      
210728s2020 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s11096-020-01054-9 $2 doi
035    __
$a (PubMed)32430883
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Stewart, Derek $u College of Pharmacy, QU Health, Qatar University, Doha, Qatar. d.stewart@qu.edu.qa
245    12
$a A survey of the European Society of Clinical Pharmacy members' research involvement, and associated enablers and barriers / $c D. Stewart, V. Paudyal, C. Cadogan, A. Hazen, B. Okuyan, M. Lutters, M. Henman, D. Fialová
520    9_
$a Background Building research capacity of European Society of Clinical Pharmacy (ESCP) members aligns to the organisation's aim of advancing research. Objective To determine members' aspirations and needs in research training and practice, and to explore ways in which ESCP could provide support. Setting ESCP's international membership. Method Cross-sectional survey of members in 2018, followed by focus groups with samples of respondents attending an ESCP symposium. Survey items were: research activities; interests, experience and confidence; and Likert statements on research conduct. Principal component analysis (PCA) clustering of Likert statements from a previous study was used, with scores for each component calculated. Focus groups discussed barriers to research and how ESCP could provide support. Data analysis involved collating and comparing all themes. Main outcome measures Research interest, experience and confidence; attitudinal items; barriers to research; ESCP support. Results The response rate was 16.7% (83/499), with 89.2% (n = 74) involved in research and 79.5% (n = 66) publishing research in the preceding 2 years. While overwhelmingly positive, responses were more positive for research interest than experience or confidence. PCA component scores (support/opportunities, motivation/outcomes, and roles/characteristics) were positive. Thirteen members participated in focus groups, identifying barriers of: insufficient collaboration; lack of knowledge, skills, training; unsupportive environment; insufficient time; and limited resources. ESCP could support through mentorship, collaboration, education and funding. Conclusion Study participants were highly active, interested, experienced, confident and positive regarding research. There is an opportunity for ESCP to harness these activities and provide support in the form of mentoring, education and training, and facilitating collaboration.
650    _2
$a dospělí $7 D000328
650    12
$a budování kapacit $7 D057191
650    _2
$a kooperační chování $7 D003299
650    _2
$a průřezové studie $7 D003430
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a zjišťování skupinových postojů $7 D017144
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a školitelé $7 D008611
650    _2
$a lidé středního věku $7 D008875
650    _2
$a výzkum v lékárnictví $x organizace a řízení $7 D000070838
650    _2
$a analýza hlavních komponent $7 D025341
650    _2
$a společnosti farmaceutické $x organizace a řízení $7 D012957
650    _2
$a průzkumy a dotazníky $7 D011795
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Paudyal, Vibhu $u School of Pharmacy, University of Birmingham, Birmingham, UK
700    1_
$a Cadogan, Cathal $u School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland
700    1_
$a Hazen, Ankie $u Centre for Pharmacy Postgraduate Education, The University of Manchester, Manchester, UK
700    1_
$a Okuyan, Betul $u Marmara University, Istanbul, Turkey
700    1_
$a Lutters, Monika $u Kantonsspital Baden, Baden, Switzerland
700    1_
$a Henman, Martin $u The School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland
700    1_
$a Fialová, Daniella $u Charles University in Prague, Prague, Czech Republic $u Department of Geriatrics and Gerontology, 1st Faculty of Medicine, Prague, Czech Republic
773    0_
$w MED00180241 $t International journal of clinical pharmacy $x 2210-7711 $g Roč. 42, č. 4 (2020), s. 1073-1087
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32430883 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101927 $b ABA008
999    __
$a ok $b bmc $g 1690975 $s 1140744
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 42 $c 4 $d 1073-1087 $e 20200519 $i 2210-7711 $m International journal of clinical pharmacy $n Int J Clin Pharm $x MED00180241
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Možnosti archivace